Covered recipient · General Payments record
JULIE WIDMAR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$11,698.30
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,740.00 | 2 |
| Travel and Lodging | $1,114.22 | 4 |
| Food and Beverage | $564.11 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $4,620.64 | 10 |
| TG THERAPEUTICS, INC. | $592.98 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $166.91 | 4 |
| GENZYME CORPORATION | $37.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $125.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414784 | CMS |
| Amgen Inc. | $186.67 | 08/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117414786 | CMS |
| Amgen Inc. | $23.57 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414788 | CMS |
| Amgen Inc. | $23.57 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414790 | CMS |
| Amgen Inc. | $350.00 | 08/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117414792 | CMS |
| Amgen Inc. | $47.14 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414794 | CMS |
| Amgen Inc. | $47.14 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414796 | CMS |
| Amgen Inc. | $531.55 | 08/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117414798 | CMS |
| Amgen Inc. | $46.00 | 08/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117414800 | CMS |
| Amgen Inc. | $3,240.00 | 08/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117414802 | CMS |
| GENZYME CORPORATION | $37.80 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139654607 | CMS |
| Novartis Pharmaceuticals Corporation | $25.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087375224 | CMS |
| Novartis Pharmaceuticals Corporation | $24.80 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087375228 | CMS |
| Novartis Pharmaceuticals Corporation | $94.50 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087375238 | CMS |
| Novartis Pharmaceuticals Corporation | $22.10 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087375230 | CMS |
| TG Therapeutics, Inc. | $35.23 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136873561 | CMS |
| TG Therapeutics, Inc. | $29.86 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136873573 | CMS |
| TG Therapeutics, Inc. | $500.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136873637 | CMS |
| TG Therapeutics, Inc. | $27.89 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136873631 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.